Completed Clinical Trials

Standard Chemotherapy With of Without Axitinib in Malignant Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 32

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: NL25655.031.08

Study First Received: September 27, 2010

Last Updated: February 27, 2017

Estimated Primary Completion Date: November 13, 2012

 

Primary Outcome Measures:

To test the impact of the addition of axitinib to standaard chemotherapy treatment on histology samples|the side effects of the standard chemotherapy and the additional risks related to axitinib use

Sponsors and Collaborators:

The Netherlands Cancer Institute|Pfizer

Website Link: https://ClinicalTrials.gov/show/NCT01211275

Leave a Reply

Call Now